CMS Seeks Feedback on Medicare $2 Drug List Model, Sample $2 Drug List, and Outreach
Biden-Harris Administration Takes Next Step on Proposed Model to Lower Prescription Drug Costs for People with Medicare
Newsroom Homepage
Listing of Newsroom articles
Press Releases
Biden-Harris Administration Takes Next Step on Proposed Model to Lower Prescription Drug Costs for People with Medicare
CMS Seeks Feedback on Medicare $2 Drug List Model, Sample $2 Drug List, and Outreach Read more about Biden-Harris Administration Takes Next Step on Proposed Model to Lower Prescription Drug Costs for People with Medicare
Fact Sheets
JYNNEOS Coverage Fact Sheet
The CDC’s Advisory Committee on Immunization Practices (ACIP) recommends vaccination with the 2-dose JYNNEOS vacine series for persons aged 18 years and older at risk for mpox. For a summary on mpox vaccine recommendations, click here. Health insurance coverage policies for JYNNEOS include: Medicaid Read more about JYNNEOS Coverage Fact Sheet
CMS Round Up
CMS Roundup (October. 4, 2024)
Today, the Centers for Medicare & Medicaid Services (CMS) provides an at-a-glance summary of news from around the agency. CMS Publishes Case Study on How it Prevented Payment of Potentially Fraudulent Claims September 23: CMS' Center for Program Integrity published a case study detailing how CMS Read more about CMS Roundup (October. 4, 2024)
Fact Sheets
HHS Notice of Benefit and Payment Parameters for 2026 Proposed Rule
Introduction The Affordable Care Act (ACA) is more popular than ever: A new report shows that nearly 50 million people – or one in seven Americans – have had ACA Marketplace coverage at some point. [1] Under President Biden and Vice President Harris, ACA coverage has become more affordable than ever Read more about HHS Notice of Benefit and Payment Parameters for 2026 Proposed Rule
Press Releases
HHS Releases Final Guidance for Second Cycle of Historic Medicare Drug Price Negotiation Program
Final guidance builds on success of the first cycle of drug price negotiations and details how HHS will help ensure negotiated prices reach people with Medicare in 2026 and 2027 Read more about HHS Releases Final Guidance for Second Cycle of Historic Medicare Drug Price Negotiation Program
News Alert